One measures the risk of stroke; the other, the risk of bleeding. How they are used together without confusing them.
In non-valvular atrial fibrillation, the big decision is whether to anticoagulate. Two scores that measure opposite things, and complement each other, are used for it.
It adds embolic risk factors: heart failure, hypertension, age (75 or older is worth 2 points), diabetes, previous stroke or embolism (worth 2), vascular disease, age 65-74 and female sex. The higher it is, the higher the risk of stroke and the stronger the indication to anticoagulate. See the CHA₂DS₂-VASc calculator.
It adds bleeding risk factors: hypertension, abnormal kidney or liver function, stroke, previous bleeding, labile INR, age over 65 and drugs or alcohol. A value of 3 or more indicates a high bleeding risk. See the HAS-BLED calculator.
A high HAS-BLED is NOT a reason not to anticoagulate. It serves to identify and correct modifiable factors (control blood pressure, improve the INR, stop NSAIDs). What sets the decision to anticoagulate is the CHA₂DS₂-VASc; HAS-BLED only says who needs closer monitoring.
In general, anticoagulation is given with a CHA₂DS₂-VASc of 2 or more in men (3 or more in women), and is considered with 1 (men) or 2 (women). HAS-BLED accompanies that decision; it does not veto it.
The typical question sets the two scores against each other: CHA₂DS₂-VASc measures thrombotic risk (do I anticoagulate?) and HAS-BLED measures bleeding risk (with what precautions?). The classic error is to believe that a high HAS-BLED contraindicates anticoagulation: it does not, it only requires correcting the modifiable bleeding factors (hypertension, alcohol, drugs) and closer follow-up. The decision to anticoagulate is based on the CHA₂DS₂-VASc: men with 2 or more and women with 3 or more are anticoagulated (it is considered with 1 and 2, respectively), almost always with direct oral anticoagulants (DOACs) rather than warfarin, except in rheumatic mitral valve disease or a mechanical prosthesis, where the drug is warfarin. Atrial fibrillation multiplies the risk of cardioembolic stroke, and that is the underlying reason for the whole topic.
▶ Play today's clinical case← All articles · Medical score calculators · Versión en español